​
Login / Signup
Xue-Bin Ran
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Toll Like Receptor
Dendritic Cells
Immune Response
Squamous Cell
Top Venues
Cancer research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xue-Bin Ran
,
Ling-Wen Ding
,
Qiao-Yang Sun
,
Henry Yang
,
Jonathan W Said
,
Zhentang Lao
,
Vikas Madan
,
Pushkar Dakle
,
Jin-Fen Xiao
,
Xinyi Loh
,
Ying Li
,
Liang Xu
,
Xiao-Qiang Xiang
,
Ling-Zhi Wang
,
Boon Cher Goh
,
De-Chen Lin
,
Wee-Joo Chng
,
Soo Yong Tan
,
Sudhakar Jha
,
H Phillip Koeffler
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy.
Cancer research
83 (6) (2023)
Xue-Bin Ran
,
Ling-Wen Ding
,
Qiao-Yang Sun
,
Henry Yang
,
Jonathan W Said
,
Zhentang Lao
,
Vikas Madan
,
Pushkar Dakle
,
Jin-Fen Xiao
,
Xinyi Loh
,
Ying Li
,
Liang Xu
,
Xiao-Qiang Xiang
,
Ling-Zhi Wang
,
Boon Cher Goh
,
De-Chen Lin
,
Wee-Joo Chng
,
Soo Yong Tan
,
Sudhakar Jha
,
H Phillip Koeffler
Targeting RNA exonuclease XRN1 potentiates efficacy of cancer immunotherapy.
Cancer research
(2023)
Xue-Bin Ran
,
Ling-Wen Ding
,
Qiao-Yang Sun
,
Henry Yang
,
Jonathan W Said
,
Zhentang Lao
,
Vikas Madan
,
Pushkar Dakle
,
Jin-Fen Xiao
,
Xinyi Loh
,
Ying Li
,
Liang Xu
,
Xiao-Qiang Xiang
,
Ling-Zhi Wang
,
Boon Cher Goh
,
De-Chen Lin
,
Wee-Joo Chng
,
Soo Yong Tan
,
Sudhakar Jha
,
H Phillip Koeffler
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy.
Cancer research
83 (6) (2023)